Safe and Secure Medicine Supply for Hardworking Americans Act of 2020
Latest action · May 15, 2020 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 15, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Safe and Secure Medicine Supply for Hardworking Americans Act of 2020
This bill bans in certain instances the importation of drugs and medical devices from a foreign manufacturing facility that has been subject to a recall, imposes additional duties on imported drugs, and contains other related provisions.
The Food and Drug Administration shall ban drug or device imports from a foreign facility for a specified amount of time if a drug or device from that facility has been subject to a Class I or Class II recall. The bill imposes civil monetary fines for any individual or entity that violates such an import ban.
The bill also imposes, on top of any other duties, a 25% duty on drugs imported from China, a 20% duty on drugs imported from India, and a 10% duty on drugs imported from any other country.
The duties and fines established under this bill shall go into a fund for supporting and incentivizing new pharmaceutical or medical device manufacturing in the United States.
The bill also requires each drug sold to state on its label the country of origin of each active pharmaceutical ingredient.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Jun 18, 2020 to Jul 1, 2020.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-TX | Ron Wright | Jun 18, 2020 | |
| R-IN | James R. Baird | Jul 1, 2020 | |
| R-WI | Thomas P. Tiffany | Jul 1, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 15, 2020 |
| House | Ways and Means Committee | Referred May 15, 2020 |
Actions 2
Everything that happened, newest first.
- May 15, 2020Introduced in House
- May 15, 2020Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 92, May 15, 2020, page H2261.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to prohibit the importation of a drug or device that was manufactured at a banned foreign facility, to create incentives for pharmaceutical or device companies to increase manufacturing capacity in the United States, and for other purposes.
- Short Title(s) as Introduced
- Safe and Secure Medicine Supply for Hardworking Americans Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Asia
- China
- Civil actions and liability
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Employment and training programs
- Government information and archives
- Government trust funds
- Health
- Health information and medical records
- India
- Manufacturing
- Prescription drugs
- Tariffs
- Trade restrictions
Text 1
Each version as it was printed, newest first.
- May 15, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
